Innoviva, Inc. ( INVA) - Key Metrics
INVA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.63 | -$1.14 | $0.71 | $0.70 |
| 2026Q1 | $1.32 | $2.52 | $0.48 | $0.47 |
| 2025Q4 | $1.58 | $2.19 | $0.73 | $0.71 |
| 2025Q3 | $1.56 | $1.30 | $0.72 | $0.70 |
| 2025Q2 | $1.60 | $1.01 | $0.70 | $0.70 |
INVA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.98 |
| 2026Q1 | 0% | 2.31 |
| 2025Q4 | 0% | 2.28 |
| 2025Q3 | 0% | 3.51 |
| 2025Q2 | 0% | 4.97 |
INVA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.09% | 0% |
| 2026Q1 | 2.01% | 0% |
| 2025Q4 | 3.57% | 0% |
| 2025Q3 | 3.86% | 0% |
| 2025Q2 | 3.49% | 0% |
INVA
Price: $21.19
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.32 USD
P/E Ratio: 4.80
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 549332
Ebitda: 66.9 millionMarket Capitalization: 1.5 billion